| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 47.530 | 48.757 | 43.760 | 58.421 | 62.824 | 59.250 | 53.438 | 50.499 | 51.870 | 61.823 |
| Total Income - EUR | 48.049 | 49.154 | 44.411 | 58.701 | 63.407 | 59.745 | 53.795 | 54.555 | 51.870 | 61.823 |
| Total Expenses - EUR | 48.726 | 48.240 | 47.003 | 59.271 | 57.685 | 65.799 | 59.363 | 67.966 | 73.125 | 88.664 |
| Gross Profit/Loss - EUR | -677 | 914 | -2.592 | -570 | 5.722 | -6.055 | -5.569 | -13.411 | -21.255 | -26.842 |
| Net Profit/Loss - EUR | -2.118 | -69 | -3.035 | -1.157 | 5.088 | -6.632 | -6.107 | -13.956 | -21.774 | -27.792 |
| Employees | 3 | 2 | 3 | 3 | 2 | 4 | 3 | 4 | 4 | 4 |
Check the financial reports for the company - Gyn & Dany Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.433 | 1.257 |
| Current Assets | 13.798 | 14.739 | 18.342 | 13.823 | 12.097 | 10.576 | 11.233 | 15.017 | 16.686 | 12.450 |
| Inventories | 13.538 | 14.446 | 17.933 | 13.282 | 11.421 | 10.219 | 10.906 | 14.464 | 15.496 | 11.799 |
| Receivables | 0 | 90 | 97 | 53 | 96 | 89 | 177 | 216 | 766 | 228 |
| Cash | 260 | 202 | 312 | 488 | 580 | 268 | 149 | 337 | 424 | 424 |
| Shareholders Funds | -5.253 | -5.268 | -8.214 | -9.220 | -3.954 | -10.511 | -16.385 | -24.266 | -45.966 | -73.501 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 19.051 | 20.007 | 26.556 | 23.043 | 16.050 | 21.087 | 27.617 | 39.283 | 64.086 | 87.208 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Gyn & Dany Srl